SIGA (SIGA Technologies) Interest Expense (Positive)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SIGA SIGA Technologies Inc SIGA
62 GF Score
Price $2.91
GF Value $2.55
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is SIGA Technologies Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

SIGA
62GF Score
SIGA Technologies Inc SIGA
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SIGA Technologies (SIGA) Overvalued in 2026?

Based on GuruFocus' analysis, SIGA Technologies stock appears to be overvalued. The current stock price of $2.91 is trading 13.9% above its estimated GF Value™ of $2.55. GuruFocus considers SIGA Technologies to be Modestly Overvalued.

Key valuation signals for SIGA:

  • Interest Expense (Positive):
  • GF Value™: $2.55 vs. price of $2.91 (13.9% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the SIGA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SIGA Technologies Business Description

Address 31 East 62nd Street, New York, NY, USA, 10065
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
62GF Score

Get the complete analysis for SIGA

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.91
Price
$2.55
GF Value